Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
about
Acute oxalate nephropathy due to 'Averrhoa bilimbi' fruit juice ingestionBariatric surgery and the kidney-much benefit, but also potential harmNephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney diseaseManagement of obesity-induced kidney disease: a critical review of the literatureNephrolithiasis after bariatric surgery for obesity.Kidney stone risk following modern bariatric surgery.Hyperoxaluria after modern bariatric surgery: case series and literature review.Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.Comparison of the absorption of calcium carbonate and calcium citrate after Roux-en-Y gastric bypass.Kidney stones are common after bariatric surgery.Metaphylaxis, diet and lifestyle in stone disease.Metabolic syndrome, obesity and kidney stones.Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.Oxalate nephropathy associated with chronic pancreatitis.The effect of gastric banding on kidney stone diseaseOxalate nephropathy in systemic sclerosis: Case series and review of the literature.Response to dietary oxalate after bariatric surgery.Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.Extracellular nucleotides inhibit oxalate transport by human intestinal Caco-2-BBe cells through PKC-δ activation.Prevalence of hyperoxaluria after bariatric surgery.Oxalate nephropathy: An important cause of renal failure after bariatric surgery.Urolithiasis and crohn's disease.Use of sevelamer hydrochloride as an oxalate binderObesity management in adults with CKD.Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric BypassProspective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.Urolithiasis in inflammatory bowel disease and bariatric surgery.Consequences of morbid obesity on the kidney. Where are we going?Bariatric surgery and renal function: a precarious balance between benefit and harm.Gastrointestinal disorders and renal failure: exploring the connection.Treating the obese dialysis patient: challenges and paradoxes.Acute oxalate nephropathy associated with orlistat: a case report with a review of the literature.Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies.Metabolic and endocrinological factors related to nephrolithiasis pre and post multiple techniques of bariatric surgery: a sistematic review.Kidney stone risk following Roux-en-Y gastric bypass surgery.Stone formation and management after bariatric surgery.The mechanistic basis of hyperoxaluria following gastric bypass in obese rats.The management of patients with enteric hyperoxaluria.Renal glomerular and tubular injury after gastric bypass in obese rats.Kidney Stones After Bariatric Surgery: Risk Assessment and Mitigation.
P2860
Q24631710-A23F2BE6-2EA2-4E56-8FA6-77F598033203Q26850597-8ED0E5BE-6CA0-4E39-B699-ABCF16968050Q26865804-46A6233E-EC33-49DB-BE90-ADECD0DED212Q27027141-A3FA8547-BDA9-4E6B-9DF7-2AFB0BE2A9C8Q33700670-6341E6A5-30F1-4142-914C-A3B68474C1F6Q33759672-D6B7F60E-0089-4DA1-BBF7-22133A46C2DEQ33918143-4889FC00-E15F-48AD-BDC3-CCFDB5E9BD2EQ34809797-CDF5FE4B-CBA0-4E5B-ACEB-2C80E1DE4056Q34980676-AE4074AD-4721-4AE1-A246-733773F9E524Q35243688-3A0AF1FC-1B9B-4DD6-817B-937A1B80AB5BQ35643131-0A0E5C0C-C6B6-4589-B8E3-61EC1E18BB79Q35643215-313832E1-43E2-4CA7-A226-3A14193CABFEQ35801654-49BE9F35-F8C5-4F91-B957-B4513CC67D22Q35985685-3EAE440B-6DDB-4DDE-8024-4A8C9980F3CFQ36021546-AC3C7B50-37D3-415A-AB92-A9132D00DE05Q36307532-5C4CA788-C2B0-40F5-B528-8F3FE9F7C5C8Q36443214-F3DC1D8A-DECF-4C13-84F0-F60FD1C87052Q36947314-83CB2032-6A6C-41C8-8E56-F885D32C4FA2Q37050910-823EB252-C270-4D70-BB92-E6176BFEB88EQ37088328-A5D39545-14C7-4971-9583-4F01E30FAB46Q37091166-C8534A58-43DB-48D5-9B7D-7640E47280AEQ37094276-1927026F-741D-488F-BE14-1F81B6CC7CABQ37127562-3E8F9C71-DE02-47A0-9F70-CB9B06620283Q37356229-80318ECE-B46D-48AC-9F61-DE913C8C0577Q37356372-A85DEB99-76D6-4B07-849A-CBFD92B1D4E4Q37361543-10CBDDBC-4E69-4178-8938-C4656063D7BFQ37399700-C1C07EEF-6B37-4542-9F1D-5AC2EA5F34C0Q37511029-61558304-554A-49BA-9E92-CEB9CCF60BA5Q37766687-0E5953E2-E5D8-4900-B168-E08809394AFEQ37770400-1A2FF3BD-F256-4148-B412-ACB99EEC1ED7Q37975219-72254BFB-2F96-482C-BE22-DC294AEE37CAQ38187985-E2269C63-EFEC-4CCE-A133-BE021EF77338Q38223535-4737D166-B366-48EC-AC13-EE3F5E2A8B37Q38269576-3EAF82DA-E5B8-4DB7-8539-4DCC2BA8884BQ38282915-6C15426D-8BE8-4453-AB9C-E6BEF184FD0EQ38409982-E8ED28B8-45D6-4328-8ACF-3CDAFEAC5210Q38411211-2411E5A9-DEA4-4DAB-BF00-260A6D5933A6Q38662272-82976E94-A9E2-4740-99D5-A1F65C8DD10BQ38771124-6F9A2F6D-374C-4BBC-9EAC-15D09B47D50AQ38807855-DF932835-CE36-4224-98D8-0ECC8C758025
P2860
Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Enteric hyperoxaluria, nephrol ...... s of Roux-en-Y gastric bypass.
@ast
Enteric hyperoxaluria, nephrol ...... s of Roux-en-Y gastric bypass.
@en
type
label
Enteric hyperoxaluria, nephrol ...... s of Roux-en-Y gastric bypass.
@ast
Enteric hyperoxaluria, nephrol ...... s of Roux-en-Y gastric bypass.
@en
prefLabel
Enteric hyperoxaluria, nephrol ...... s of Roux-en-Y gastric bypass.
@ast
Enteric hyperoxaluria, nephrol ...... s of Roux-en-Y gastric bypass.
@en
P2093
P1476
Enteric hyperoxaluria, nephrol ...... s of Roux-en-Y gastric bypass.
@en
P2093
Dawn S Milliner
John C Lieske
Michael G Sarr
Scott G Houghton
Wayne K Nelson
P304
P356
10.1016/J.SOARD.2005.07.002
P577
2005-08-26T00:00:00Z